Stock NATCO PHARMA LTD.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Calendar Natco Pharma Ltd. NSE India S.E.

Equities

INE987B01018

End-of-day quote NSE India S.E.
Other stock markets
- INR - Intraday chart for Natco Pharma Ltd.
05-28 INDIA STOCKS-Metal, pharma stocks drive Indian benchmarks higher RE
05-28 Transcript : NATCO Pharma Limited, Q4 2024 Earnings Call, May 28, 2024

Chart calendar Natco Pharma Ltd.

b4b5ef7def1f97bb08381969c301fc16.v_8RwUwAVkxv0oxRO-HN5UrHyBnLi3C6PO47KRi-RAM.h6ZdlihUMQBYsNpiY4K10xOSikGu1ETdf7txUHaOJXPvl16zFHdnKC2o-w~c6579483ceb4c219e0e705e1276bb41a

Upcoming events on Natco Pharma Ltd.

07/08/2024 Q1 2025 Earnings Release (Projected)
11/11/2024 Q2 2025 Earnings Release (Projected)
11/02/2025 Q3 2025 Earnings Release (Projected)
01/06/2025 Q4 2025 Earnings Release (Projected)

Past events on Natco Pharma Ltd.

04/07/2024 05:30 Investor Meeting - ICICI Securities
10/06/2024 11:00 Investor Meeting - J M Financial
29/05/2024 B&K Securities Trinity Investor Conference
29/05/2024 06:30 Investor Meeting - ICICI Securities
28/05/2024 06:30 Q4 2024 Earnings Call
27/05/2024 12:12 Q4 2024 Earnings Release
22/04/2024 07:30 Investor Meeting - HSBC Global
06/03/2024 06:30 Investor Meeting - ICICI Securities
28/02/2024 03:30 Investec Promoter & Founder Conference
15/02/2024 05:30 Q3 2024 Earnings Call
14/02/2024 08:38 Q3 2024 Earnings Release
15/12/2023 06:00 Investor Meeting - Kotak PCG
29/11/2023 03:30 Investor Meeting
28/11/2023 03:30 Investor Meeting - Day 1
15/11/2023 05:30 Q2 2024 Earnings Call
14/11/2023 08:44 Q2 2024 Earnings Release
29/09/2023 06:00 Annual General Meeting
10/08/2023 06:30 Q1 2024 Earnings Call
09/08/2023 10:20 Q1 2024 Earnings Release
30/05/2023 06:30 Q4 2023 Earnings Call

Annual results

Fiscal PeriodMarzo 2019 2020 2021 2022 2023 2024
Net sales
Million INR		Released
Forecast
Spread 		20 945
22 060
-5.05%		19 150
19 446
-1.52%		20 521
21 294
-3.63%		19 448
19 848
-2.02%		27 071
26 844
0.85%		39 988
39 185
2.05%
EBITDA
Million INR		Released
Forecast
Spread 		7 948
9 009
-11.77%		5 826
6 531
-10.79%		6 062
6 289
-3.61%		2 635
5 360
-50.84%		9 356
9 761
-4.15%		17 514
16 899
3.64%
EBIT
Million INR		Released
Forecast
Spread 		7 138
8 815
-19.03%		4 828
5 211
-7.35%		4 893
5 247
-6.75%		1 209
4 105
-70.55%		7 718
8 088
-4.57%		15 646
15 221
2.79%
Earnings before Tax (EBT)
Million INR		Released
Forecast
Spread 		8 247
8 947
-7.83%		5 687
6 043
-5.88%		5 796
6 107
-5.09%		2 022
5 124
-60.54%		8 619
9 068
-4.96%		16 735
16 001
4.59%
Net income
Million INR		Released
Forecast
Spread 		6 444
6 969
-7.54%		4 608
4 832
-4.64%		4 409
4 739
-6.95%		1 700
3 978
-57.26%		7 153
7 188
-0.49%		13 883
13 212
5.08%
EPS
INR		Released
Forecast
Spread 		34,9
37,8
-7.75%		25,3
28,1
-10.08%		24,2
26,0
-7.15%		9,32
21,9
-57.44%		39,2
39,5
-0.77%		77,3
73,2
5.61%
Announcement Date27/05/1917/06/2017/06/2130/05/2229/05/2327/05/24

Quarterly results

Fiscal PeriodMarzo 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales
Million INR		Released
Forecast
Spread 		3 313
4 556
-27.29%		4 103
4 479
-8.4%		3 772
4 390
-14.08%		5 605
4 620
21.31%		5 968
5 662
5.4%		8 846
8 159
8.42%		4 321
6 309
-31.51%		4 925
5 421
-9.14%		8 979
8 321
7.91%		11 405
11 402
0.02%
10 790


5 742


9 922


13 834

EBITDA
Million INR		Released
Forecast
Spread 		762
1 268
-39.91%		1 098
1 179
-6.84%		705
1 134
-37.82%		1 018
1 145
-11.05%		-186
2 002
-109.29%		3 953
3 662
7.93%		953
2 034
-53.14%		1 059
1 322
-19.91%		3 391
3 606
-5.95%		5 280
5 247
0.63%
4 930


1 284


4 376


7 325

EBIT
Million INR		Released
Forecast
Spread

































692


3 504


9 664

Earnings before Tax (EBT)
Million INR		Released
Forecast
Spread


910
853
6.68%		698
1 067
-34.58%		910
1 144
-20.45%		-496
1 323
-137.49%		3 858
2 889
33.54%


814
833
-2.28%		3 244
1 583
104.93%		5 000
4 273
17.01%
4 672





4 732


7 960

Net income
Million INR		Released
Forecast
Spread 		530
1 027
-48.39%		750
779
-3.69%		651
775
-15.96%		804
862
-6.69%		-505
1 368
-136.92%		3 204
2 192
46.17%		568
1 385
-59%		623
942
-33.87%		2 758
2 596
6.22%		4 203
3 957
6.22%
5 355


833


3 241


6 204

EPS
INR		Released
Forecast
Spread


4,11
4,35
-5.52%		3,57
4,80
-25.63%		4,40
4,60
-4.35%		-2,77
7,30
-137.95%		17,6
12,4
41.53%		3,11
5,10
-39.02%		3,41
3,90
-12.56%		15,1
6,80
122.21%		23,3
19,0
22.42%
21,4


3,68


15,0


41,3

Announcement Date17/06/2112/08/2111/11/2114/02/2230/05/2209/08/2210/11/2209/02/2329/05/2309/08/23----

Upcoming sector events for Natco Pharma Ltd.

10/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2025 Earnings Release
15/07/2024 CAMURUS AB: Q2 2024 Earnings Release
16/07/2024 GLAND PHARMA LIMITED: Q1 2025 Earnings Release (Projected)
17/07/2024 11:45 JOHNSON & JOHNSON: Q2 2024 Earnings Release
17/07/2024 JUBILANT PHARMOVA LIMITED: Q1 2025 Earnings Release (Projected)
18/07/2024 06:00 NOVARTIS AG: Q2 2024 Earnings Release
18/07/2024 TEYI PHARMACEUTICAL GROUP CO.,LTD: Q2 2024 Earnings Release
21/07/2024 GLAXOSMITHKLINE PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
21/07/2024 ALMIRALL, S.A.: Q2 2024 Earnings Release
22/07/2024 TORRENT PHARMACEUTICALS LIMITED: Q1 2025 Earnings Release (Projected)
More events

Past sector events for Natco Pharma Ltd.

03/07/2024 HISAMITSU PHARMACEUTICAL CO., INC.: Q1 2024 Earnings Release (Projected)
21/06/2024 16:28 DEVA HOLDING: Q1 2024 Earnings Release
13/06/2024 22:21 EIS ECZACIBASI ILAÇ, SINAI VE FINANSAL YATIRIMLAR SANAYI VE TICARET: Q1 2024 Earnings Release
11/06/2024 06:30 BORA PHARMACEUTICALS CO., LTD.: June 2024 Sales and Revenue Release
07/06/2024 11:33 SCINOPHARM TAIWAN, LTD.: May 2024 Sales and Revenue Release
07/06/2024 10:17 LOTUS PHARMACEUTICAL CO., LTD.: May 2024 Sales and Revenue Release
30/05/2024 13:08 SUVEN PHARMACEUTICALS LIMITED: Q4 2024 Earnings Release
30/05/2024 12:00 ROIVANT SCIENCES LTD.: Q4 2023 Earnings Release
30/05/2024 07:24 MARKSANS PHARMA LIMITED: Q4 2024 Earnings Release
29/05/2024 13:00 FDC LIMITED: Q4 2024 Earnings Release
  1. Stock Market
  2. Equities
  3. NATCOPHARM Stock
  4. Stock
  5. Calendar Natco Pharma Ltd.